SE441042B - Sett att pavisa rheumatoida faktorer - Google Patents

Sett att pavisa rheumatoida faktorer

Info

Publication number
SE441042B
SE441042B SE7609906A SE7609906A SE441042B SE 441042 B SE441042 B SE 441042B SE 7609906 A SE7609906 A SE 7609906A SE 7609906 A SE7609906 A SE 7609906A SE 441042 B SE441042 B SE 441042B
Authority
SE
Sweden
Prior art keywords
rheumatoida
pavisa
factors
rheumatoida factors
pavisa rheumatoida
Prior art date
Application number
SE7609906A
Other languages
English (en)
Swedish (sv)
Other versions
SE7609906L (sv
Inventor
R Hellgren
L E Wide
Original Assignee
Pharmacia Diagnostics Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Diagnostics Ab filed Critical Pharmacia Diagnostics Ab
Priority to SE7609906A priority Critical patent/SE441042B/xx
Priority to DE2707881A priority patent/DE2707881C2/de
Priority to NL7708078A priority patent/NL7708078A/xx
Priority to US05/818,646 priority patent/US4153417A/en
Priority to CA283,447A priority patent/CA1076937A/en
Priority to FR7722925A priority patent/FR2364456A1/fr
Priority to GB31492/77A priority patent/GB1576400A/en
Priority to JP52090878A priority patent/JPS6057544B2/ja
Publication of SE7609906L publication Critical patent/SE7609906L/xx
Publication of SE441042B publication Critical patent/SE441042B/xx

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/962—Prevention or removal of interfering materials or reactants or other treatment to enhance results, e.g. determining or preventing nonspecific binding
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/80—Fluorescent dyes, e.g. rhodamine
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/804—Radioisotope, e.g. radioimmunoassay
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/819—Multifunctional antigen or antibody
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/821—Chemistry: analytical and immunological testing involving complement factors or complement systems
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/826—Additives, e.g. buffers, diluents, preservatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Rehabilitation Therapy (AREA)
  • Biotechnology (AREA)
  • Rheumatology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
SE7609906A 1976-09-08 1976-09-08 Sett att pavisa rheumatoida faktorer SE441042B (sv)

Priority Applications (8)

Application Number Priority Date Filing Date Title
SE7609906A SE441042B (sv) 1976-09-08 1976-09-08 Sett att pavisa rheumatoida faktorer
DE2707881A DE2707881C2 (de) 1976-09-08 1977-02-24 Verfahren zum Nachweis von rheumatoiden Faktoren
NL7708078A NL7708078A (nl) 1976-09-08 1977-07-20 Werkwijze voor het aantonen van rheumatoide factoren.
US05/818,646 US4153417A (en) 1976-09-08 1977-07-25 Method of indicating rheumatoid factors
CA283,447A CA1076937A (en) 1976-09-08 1977-07-25 Method of indicating rheumatoid factors
FR7722925A FR2364456A1 (fr) 1976-09-08 1977-07-26 Procede pour deceler et identifier des facteurs de rhumatismes
GB31492/77A GB1576400A (en) 1976-09-08 1977-07-27 Method of indicating rheumatoid factors
JP52090878A JPS6057544B2 (ja) 1976-09-08 1977-07-28 リウマトイド因子の指示方法

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE7609906A SE441042B (sv) 1976-09-08 1976-09-08 Sett att pavisa rheumatoida faktorer

Publications (2)

Publication Number Publication Date
SE7609906L SE7609906L (sv) 1978-03-09
SE441042B true SE441042B (sv) 1985-09-02

Family

ID=20328828

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7609906A SE441042B (sv) 1976-09-08 1976-09-08 Sett att pavisa rheumatoida faktorer

Country Status (8)

Country Link
US (1) US4153417A (ja)
JP (1) JPS6057544B2 (ja)
CA (1) CA1076937A (ja)
DE (1) DE2707881C2 (ja)
FR (1) FR2364456A1 (ja)
GB (1) GB1576400A (ja)
NL (1) NL7708078A (ja)
SE (1) SE441042B (ja)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4302536A (en) * 1978-08-15 1981-11-24 Longenecker Robert W Colorimetric immunoassay process
US4342566A (en) * 1980-02-22 1982-08-03 Scripps Clinic & Research Foundation Solid phase anti-C3 assay for detection of immune complexes
US4434227A (en) * 1982-02-08 1984-02-28 Abbott Laboratories Immunoassay for class specific immunoglobulin antibodies
US4450231A (en) * 1982-03-31 1984-05-22 Biostar Medical Products, Inc. Immunoassay for determination of immune complexes with polymer-coated plastic base
US4582793A (en) * 1982-10-29 1986-04-15 Research Corporation Anti-RNA polymerase I antibody test for the diagnosis of rheumatological diseases
SE8304836D0 (sv) * 1983-09-09 1983-09-09 Pharmacia Ab Sett att bestemma forendringar i ledbrosk
CA1261257A (en) * 1984-09-19 1989-09-26 Helgi Valdimarsson Prognostic value of rheumatoid factor isotypes and their association with disease activity
US4914041A (en) * 1988-02-12 1990-04-03 Beckman Instruments, Inc. Reagent and method for detecting rheumatoid factor
US5066789A (en) * 1988-09-30 1991-11-19 Neorx Corporation Targeting substance-diagnostic/therapeutic agent conjugates having Schiff base linkages
EP0434765B1 (en) * 1988-09-30 1995-11-08 Neorx Corporation Targeting substance-diagnostic/therapeutic agent conjugates having schiff base linkages
US4986979A (en) * 1989-03-14 1991-01-22 Neorx Corporation Imaging tissue sites of inflammation
JPH02144560U (ja) * 1989-05-12 1990-12-07
US6303758B1 (en) 1996-11-08 2001-10-16 Matsushita Electric Industrial Co., Ltd. Dye-labeled and polymerized antibody and method for preparing the same
US6300480B1 (en) 1996-11-08 2001-10-09 Matsushita Electric Industrial Co., Ltd. Dye-labeled protein conjugate and method for preparing the same
US6303759B1 (en) 1996-11-08 2001-10-16 Matsushita Electric Industrial Co., Ltd. Dye-labeled and polymerized antibody and method for preparing the same
JP3601972B2 (ja) * 1998-05-14 2004-12-15 松下電器産業株式会社 色素標識タンパク質複合体およびその製造方法
JP3625250B2 (ja) * 1998-05-14 2005-03-02 松下電器産業株式会社 色素標識重合抗体およびその製造方法
JPH11322798A (ja) * 1998-05-14 1999-11-24 Matsushita Electric Ind Co Ltd 色素標識重合抗体およびその製造方法
EP1311820B1 (en) 2000-07-14 2015-02-11 Janssen Diagnostics, LLC Increased separation efficiency via controlled aggregation of magnetic nanoparticles
US20060159680A1 (en) * 2005-01-14 2006-07-20 Smith Henry J Targeted apherisis for the treatment of rheumatoid arthritis
US20130068691A1 (en) * 2011-08-05 2013-03-21 Henry John Smith Targeted apheresis for the treatment of rheumatoid arthritis and immune disorders

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1484727A (fr) * 1966-04-19 1967-06-16 Réactif immunologique et son procédé d'obtention
GB1179435A (en) * 1966-06-17 1970-01-28 Ortho Pharma Corp Stable Reagent for the Detection of Rheumatoid Arthritis
US3689632A (en) * 1969-01-06 1972-09-05 Kowa Co Rheumatoid agglutination test and reagent
GB1508132A (en) * 1974-05-20 1978-04-19 Technicon Instr Analysis of biological fluids

Also Published As

Publication number Publication date
FR2364456B1 (ja) 1981-08-28
JPS6057544B2 (ja) 1985-12-16
JPS5334918A (en) 1978-03-31
NL7708078A (nl) 1978-03-10
GB1576400A (en) 1980-10-08
FR2364456A1 (fr) 1978-04-07
DE2707881C2 (de) 1985-05-30
DE2707881A1 (de) 1978-03-09
CA1076937A (en) 1980-05-06
SE7609906L (sv) 1978-03-09
US4153417A (en) 1979-05-08

Similar Documents

Publication Publication Date Title
SE7805276L (sv) Sett att framstella liposomblandningar
SE433819B (sv) Sett att framstella pleterade stalror
SE433222B (sv) Sett att framstella modifierad polysackarid
SE432247B (sv) Sett att framstella dihydro-cyklosporin c
SE431935B (sv) Sett att framstella drageer
SE440779B (sv) Sett att framstella androstan-17-on-derivat
SE7606280L (sv) Sett att framstella etrar
SE441042B (sv) Sett att pavisa rheumatoida faktorer
SE435928B (sv) Sett att framstella nya 3-aryl-oxazolidin-2-oner
SE432256B (sv) Sett att framstella cellulosaalkyletrar
SE420728B (sv) Sett att framstella piperazinyliminorifamyciner
SE425736B (sv) Sett att framstella kromanon-(4)
SE430687B (sv) Sett att framstella hexanitrostilben
SE7708841L (sv) Sett att framstella rifamycinforeningar
SE420732B (sv) Sett att framstella 4-gonen-3-oner
SE7705064L (sv) Sett att framstella mikrokapslar
SE425321B (sv) Sett att reducera vanadinoxider
SE399015B (sv) Sett att framstella fiberplattor
SE7804126L (sv) Sett att framstella vulkanisat
SE410733B (sv) Sett att framstella vissa angivna oximetrar
SE7714506L (sv) Sett att framstella packningar
SE434397B (sv) Sett att framstella bens-acyl-bensimidazol-2-derivat
SE430156B (sv) Sett att framstella 2-subst-1-(omega-aminoalkoxi)-bensener
SE430505B (sv) Sett att framstella en substituerad purin
SE7713868L (sv) Sett att framstella tegel

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 7609906-8

Effective date: 19910409

Format of ref document f/p: F